This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of an innovative surgical stapling device called Cybernetic. Revmedica Inc., a for-profit manufacturer, is receiving $293,989 to develop a prototype of Cybernetic, a semi-reusable surgical stapler with a tissue-sensing mechanism. The key objectives of this Phase I project are to 1) develop the hardware components and validate the system through benchtop testing, and 2) conduct acute animal studies to assess the safety and efficacy of the prototype. This project aims to create an advanced surgical stapling device that can provide real-time feedback to surgeons, improve performance, and reduce complications and waste associated with traditional staplers. The successful completion of this Phase I effort will enable Revmedica to pursue further development, preclinical studies, and potential FDA regulatory approval in a future Phase II project.
Generated 1/28/25, 9:49 AM